Nebenwirkungen · Iclusig
Iclusig 15 mg film-coated tablets Iclusig 30 mg film-coated tablets Iclusig 45 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 19–20
HOS-128528 · Präparat HOS-096579
19 System organ class Frequency Adverse reactions Cardiac failure Myocardial infarction Cardiac failure congestive Coronary artery disease Angina pectoris Pericardial effusion Atrial fibrillation Ejection fraction decreased Acute coronary syndrome Atrial flutter Bradycardia Palpitations Common Tachycardia Left ventricular dysfunction Cardiac disorders Left ventricular hypertrophy Sinus bradycardia N-terminal prohormone brain natriuretic peptide increased Angina unstable Myocardial ischaemia Supraventricular extrasystoles Ventricular extrasystoles Electrocardiogram QT prolonged Cardiac failure chronic Brain natriuretic peptide increased Cardiac discomfort Uncommon Ischemic cardiomyopathy Arteriospasm coronary Very common Hypertension Peripheral arterial occlusive disease Peripheral ischaemia Peripheral artery stenosis Intermittent claudication Common Deep vein thrombosis Hot flush Flushing Vascular disorders Hypertensive crisis Poor peripheral circulation Splenic infarction Uncommon Embolism venous Venous thrombosis Renal artery stenosis Aneurysms Not known Artery dissections
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-31T14:12:00Z · SHA-256 4867aa10684948b4c421d8ab4cf806af86df3e9279763348c485fe3b6e3627c4 · Passage 3469950beb0a9eaa4c8d1d0cbd36e89a3d9ddf881c216d105c9dac685c26991c · Zeichen 9568–12728 im Abschnitt